Cargando…
Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study
BACKGROUND: B-cell-depleting therapies increase the risk of morbidity and mortality due to COVID-19. Evidence-based SARS-CoV-2 vaccination strategies for patients on B-cell-depleting therapies are scarce. We aimed to investigate humoral and cell-mediated immune responses to SARS-CoV-2 mRNA-based vac...
Autores principales: | Moor, Matthias B, Suter-Riniker, Franziska, Horn, Michael P, Aeberli, Daniel, Amsler, Jennifer, Möller, Burkhard, Njue, Linet M, Medri, Cesare, Angelillo-Scherrer, Anne, Borradori, Luca, Radonjic-Hoesli, Susanne, Seyed Jafari, S Morteza, Chan, Andrew, Hoepner, Robert, Bacher, Vera Ulrike, Mani, Laila-Yasmin, Iype, Joseena Mariam, Hirzel, Cédric, Maurer, Britta, Sidler, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423431/ https://www.ncbi.nlm.nih.gov/pubmed/34514436 http://dx.doi.org/10.1016/S2665-9913(21)00251-4 |
Ejemplares similares
-
Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy
por: Sidler, Daniel, et al.
Publicado: (2022) -
Cellular responses to SARS-CoV-2 vaccination after B-cell depletion: conflicting results from studies – Authors' reply
por: Moor, Matthias B, et al.
Publicado: (2022) -
The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature review
por: Njue, Linet, et al.
Publicado: (2021) -
Basophils Orchestrating Eosinophils’ Chemotaxis and Function in Allergic Inflammation
por: Iype, Joseena, et al.
Publicado: (2021) -
Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
por: Friedli, Christoph, et al.
Publicado: (2021)